Effectiveness and safety of mogamulizumab for the treatment of Sézary syndrome in very elderly patients: A real-world, multicentre, retrospective study conducted in France.

Ribereau-Gayon, E; Beylot-Barry, M; De Masson, A; Ram-Wolff, C; Bagot, M; Pham-Ledard, A; Grange, F

Ribereau-Gayon, E; Beylot-Barry, M; De Masson, A; Ram-Wolff, C; Bagot, M; Pham-Ledard, A; Grange, F.

Afiliación

Ribereau-Gayon E; Dermatology Department, Hospices Civils de Lyon, Lyon, France.
Beylot-Barry M; Dermatology Department, CHU Bordeaux, Bordeaux, France.
De Masson A; Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
Ram-Wolff C; Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
Bagot M; Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
Pham-Ledard A; Dermatology Department, CHU Bordeaux, Bordeaux, France.
Grange F; Department of Dermatology, Valence Hospital, Valence, France.

J Eur Acad Dermatol Venereol ; 2024 May 28.

Article en En | MEDLINE | ID: mdl-38804019

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google